Pancreatic Cancer Research

ResearcherUniversity of MilanNo recent work listed

Edoardo Botteri

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9023-8068; OpenAlex author ID A5024587155. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

  1. Use of non-cancer drugs and survival among patients with pancreatic adenocarcinoma: a nationwide registry-based study in Norway. Last author DOI 10.1080/0284186x.2021.1953136↗
  2. Neoadjuvant/preoperative gemcitabine for patients with localized pancreatic cancer: a meta-analysis of prospective studies. Co-author DOI 10.1245/s10434-011-2110-8↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nathalie C. Støer · 1 shared paper, 2021 · strength 0.16
  2. Erica K. Sloan · 1 shared paper, 2021 · strength 0.16
  3. Virginia Festa · 1 shared paper, 2012 · strength 0.03
  4. M. Koch · 1 shared paper, 2012 · strength 0.03
  5. Angelo Andriulli · 1 shared paper, 2012 · strength 0.03
  6. Patrick Maisonneuve · 1 shared paper, 2012 · strength 0.03
  7. Pierluigi Di Sebastiano · 1 shared paper, 2012 · strength 0.03
  8. Claudio Bassi · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.